Clinical Study for Bupi Qingfei Decoction on Reducing Recurrent Attack of Pseudomonas aeruginosa Colonized Bronchiectasis

Not Applicable

Recruiting

• Conditions: Bronchiectasis

• Registration Number: ITMCTR1900002573
• Lead Sponsor: Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Outpatient or inpatient patients who meet the diagnostic criteria of PA-colonized bronchiectasis;
2. Aged 18-70 years old;
3. Patients with lung-qi deficiency and phlegm-heat accumulation in TCM syndrome differentiation;
4. Patients with acute exacerbation at least once in the past year;
5. Those who are willing to follow the doctor's diagnosis and treatment arrangements and sign the informed consent.

Exclusion Criteria

1. Those who do not meet the above criteria for diagnosis and differentiation of TCM syndrome;
2. Pregnant or lactating women;
3. History of chronic alcoholism or drug abuse or any factors affecting compliance;
4. Low compliance during screening period;
5. Complications with cardiovascular diseases (such as acute myocardial infarction, heart failure, etc.), cerebrovascular diseases (such as cerebral infarction, cerebral hemorrhage), liver diseases (such as viral hepatitis, cirrhosis, etc.). Primary diseases such as kidney (such as glomerulonephritis, nephrotic syndrome, etc.) and hematopoietic system (such as leukemia, hematopoietic dysfunction, etc.);
6. Liver and kidney dysfunction: abnormal liver (ALT or AST) more than double the upper limit of normal value or abnormal renal function (BUN or Cr);
7. Psychiatric patients;
8. allergic constitution and allergic to this drug;
9. Hemoptysis is the main cause of bronchiectasis those who want to perform;
10. those who have participated in other clinical trials in 1 months;
11. Other situations that the researchers think are not suitable for selection.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
immunoglobulin;ESR;liver and kidney function;urinary routine;Blood Routine;CRP;